Skip to main content
letter
. 2015 Aug 3;38(4):111–113. doi: 10.18773/austprescr.2015.044

Table. The effect of P2Y12 inhibitors on cardiovascular events in smokers and non‑smokers: a meta-analysis 5.

Drug Cardiovascular events
Relative risk reduction in smokers Relative risk reduction in non-smokers
Clopidogrel
25%
8%
Prasugrel
29%
18%
Ticagrelor 17% 15%